Rare Immune Cell May Predict Immunotherapy Response in Melan

Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.

Related Keywords

New York , United States , United Kingdom , London , City Of , British , Daniel Davies , St Thoma Hospital , King College London , Francis Crick Institute , Research Fellow At King College London , National Cancer Institute , College London , Nature Cancer , Shraddha Kamdar , Research Fellow , Immune System , Treat Skin , Edward Meyer Cancer Center , Weill Cornell Medicine , Skin Cancer , Immunotherapy ,